Diagnosing Health Care Podcast
76 episodes - English - Latest episode: 8 days ago -Today’s health care industry is a high-stakes environment full of legal, policy, and regulatory-related obstacles. There are also tremendous opportunities, and in order to thrive, it is critical for executives, general counsel, and administrators to have a consistent pulse on trends and available business solutions. Subscribe to our health care podcast, Diagnosing Health Care, for thought-provoking, strategic insights from Epstein Becker Green attorneys and health care professionals.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Key Changes in Finalized Antitrust Merger Guidelines
April 11, 2024 14:10 - 27 minutes - 38.3 MBAfter nearly two years of combined efforts from the Federal Trade Commission and the Antitrust Division of the Department of Justice, the agencies jointly issued much-anticipated merger guidelines identifying the procedures and enforcement practices they will apply for evaluating potential mergers. What might these changes mean for hospitals, health systems, and other stakeholders in the health care industry? On this episode, we discuss some of the key changes in the finalized antitrust mer...
Health Equity: Behind the Buzzwords
December 14, 2023 15:02 - 19 minutes - 27.3 MBUnder the Biden administration, the Centers for Medicare & Medicaid Services published a health equity framework that drastically changed the playing field for health plans and other risk-bearing entities. In the wake of these changes, how can health plans, accountable care organizations, and other similar stakeholders successfully create and administer social determinants of health interventions as a means to advance health equity? On this episode, Epstein Becker Green attorneys Jackie Selb...
Telehealth Post-Public Health Emergency: What to Expect in 2024
December 07, 2023 15:01 - 32 minutes - 45 MBWhat trends in state laws and regulations have emerged in the post-public health emergency (PHE) era, and how do these changes impact telehealth stakeholders? At the federal level, many telehealth-related flexibilities have been extended through December 31, 2024, whereas, at the state level, there are wide variations in approach. Many states have continued to push the boundaries of existing telehealth policies, yet no two states are exactly alike in their approach to defining and regulating...
Antitrust Updates: Changes Affecting Merger Review and Enforcement in 2024 and Beyond
November 10, 2023 15:36 - 24 minutes - 34.4 MBFrom wholesale revisions of the merger guidelines to significant amendments to the Hart-Scott-Rodino premerger notification forms, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) have proposed significant changes that, if adopted, will have profound effects on merger review and enforcement for the foreseeable future. What might these changes mean for hospitals, health systems, and other stakeholders in the health care industry? On this episode, Epstein Becker Green att...
Dietary Supplements: Navigating the Regulatory Maze
November 02, 2023 14:07 - 33 minutes - 46.2 MBThe U.S. Food and Drug Administration’s (FDA’s) broad definition of “misbranding” has created some industry confusion, while the Federal Trade Commission’s (FTC’s) updates to its health products compliance guidance have done the same. In light of these recent actions, what challenges are dietary supplement manufacturers now facing? On this episode, Epstein Becker Green attorneys Jack Wenik, Teddy McCormick, Zach Taylor, and Tracey Gonzalez discuss recent updates to the FDA and FTC guideline...
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
September 28, 2023 16:30 - 31 minutes - 43.7 MBThroughout this series, we've talked about the growth of the direct access testing industry and the types of models developed to support the businesses that are using that type of testing. We've covered reimbursement considerations and physician ordering and specimen collection regulations. How does all of this come together to shape the future of the lab testing industry? On the final episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob He...
Owner's Outlook: Managing Risks in an Ever-Changing Construction Environment
August 31, 2023 14:59 - 37 minutes - 52.5 MBThe impacts of climate volatility, cybersecurity threats, artificial intelligence, and building information modeling and construction technology have increased pressure on major construction projects on top of labor availability and supply chain adversity. If your approach to delivering construction is the same as it was in early 2020, you're probably inviting more risk to your project than you want. On this episode of our Owner's Outlook series, special guest Alanna Klein, Product Direct...
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
August 01, 2023 17:41 - 32 minutes - 45.5 MBIn July, the Centers for Medicare & Medicaid Services made significant headway in its implementation of the drug pricing provisions of the Inflation Reduction Act (IRA). How can stakeholders respond to, implement, and comply with all these new provisions? On this episode, hear from special guest Sylvia Yu, Vice President and Senior Counsel of Federal Programs at PhRMA. Sylvia and Epstein Becker Green attorneys Connie Wilkinson and Alexis Boaz discuss the recent updates on the quickly movin...
Post-Dobbs: One Year Later
June 22, 2023 14:23 - 28 minutes - 39.3 MBThe Supreme Court's decision in Dobbs v. Jackson Women's Health Organization one year ago overturned 50 years of legal precedent protecting the constitutional right to abortion in the United States, leaving the question of whether and how to regulate abortion to individual states. What has happened since and what is to come? On this episode, Epstein Becker Green attorneys Amy Dow, Erin Sutton, and Jessika Tuazon examine how the Dobbs decision has impacted the legal landscape for patient acce...
Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
May 18, 2023 13:40 - 34 minutes - 47.8 MBLike the diversity of the industry itself, merger and acquisition (M&A) transactions in health care take many forms, varying in size and complexity. While buyers tend to focus on several things as part of those transactions, securing key employees post-closing is an important but sometimes overlooked issue. What are some important factors to consider when entering a transaction in a human capital-intensive industry like health care? On this special crossover episode of Diagnosing Health Care...
The Legal Battle Over Mifepristone
May 09, 2023 14:02 - 39 minutes - 54.5 MBOn April 21, 2023, the U.S. Supreme Court ruled to preserve access to the prescription abortion drug mifepristone. However, while the case continues in the U.S. Court of Appeals for the Fifth Circuit, the future of mifepristone—and the U.S. Food and Drug Administration’s authority to approve new drugs—will continue to be debated on appeal. On this episode, Epstein Becker Green attorneys Erin Sutton, Delia Deschaine, and Avery Schumacher analyze the ongoing legal battle over mifepristone and...
Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
May 04, 2023 14:15 - 39 minutes - 53.9 MBThe Inflation Reduction Act (IRA), signed into law in August 2022, included significant and controversial drug-pricing provisions. What key compliance issues must industry stakeholders consider as these provisions are put into effect? On this episode, Epstein Becker Green attorneys Leslie Norwalk, Connie Wilkinson, and Alexis Boaz discuss key considerations for the health care and life sciences industry as the Centers for Medicare & Medicaid Services works its way through the initial stages...
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
April 20, 2023 15:04 - 26 minutes - 36.4 MBA complex landscape of state laws overlays the direct access testing model, ranging from physician order requirements, such as telemedicine standards and the corporate practice of medicine doctrine, to specimen collection considerations, including how the varying options for collection could impact a model. How do these factors combine to create a roadmap for companies navigating the direct access testing industry? On the third episode of our four-part series on direct access laboratory test...
Legal and Regulatory Landscape for Psychedelics as Therapies
April 13, 2023 14:47 - 38 minutes - 52.6 MBRenewed interest in the potential benefits of psychedelic treatments has led to an upsurge in research. Is the first FDA approval of a psychedelic for therapeutic use on the horizon? On this episode, Epstein Becker Green attorneys Delia Deschaine, Lisa Gora, and Jessika Tuazon examine the history of psychedelic substances in the United States and discuss the evolving legal and regulatory considerations impacting the development, approval, distribution, and use of psychedelic therapies in th...
2023 Deal Cycle: Considerations for Transactions in Uncertain Economic Times
March 30, 2023 18:27 - 32 minutes - 45.4 MBThe Federal Reserve's steady increase of interest rates and the slowed economic growth have increased fiscal pressure on health care providers, leaving many to look for ways to bridge budget shortfalls through injections of capital, asset sales, or other strategic transactions. What options are there for providers moving forward? On this episode, Epstein Becker Green attorneys John Tishler, Ryan Cochran, and Tim Murphy discuss how the changing economic climate has impacted the 2023 deal cyc...
The End of the Public Health Emergency – What’s to Come?
March 16, 2023 13:55 - 32 minutes - 45.4 MBIn conjunction with the national COVID-19 public health emergency (PHE), the Centers for Medicare & Medicaid Services and other federal agencies have issued waivers and other declarations with the goal of giving providers flexibility in order to render services during the PHE. How should stakeholders prepare for the end of the PHE on May 11, 2023? On this episode, Epstein Becker Green attorneys Amy Lerman, Jenny Nelson Carney, and Dan Fahey discuss the expiration of the PHE and the impact it...
Direct Access Laboratory Testing: Reimbursement & Compliance
March 09, 2023 14:59 - 36 minutes - 50.8 MBWhen analyzing the lifecycle of any health care product, a key component to consider is how much the product will cost and who will pay for it. What unique challenges do direct access tests pose when it comes to reimbursement and related compliance requirements? On the second episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob Hearn and Megan Robertson and EBG Advisor Dr. Joel Brill discuss coverage and reimbursement for direct access test...
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
February 23, 2023 14:57 - 33 minutes - 45.8 MBWhat are the various factors impacting stakeholders in the direct access testing industry? By the end of this four-part series on direct access laboratory testing, listeners will have gained insight into how to navigate the complex regulatory and legal regimes that govern the process of making lab tests available directly to patients and understand the aspects that will dictate how their operations should be structured. On this episode, Epstein Becker Green attorneys Amy Dow, Bob Hearn, Jam...
Unpacking FDA's Final Clinical Decision Support Guidance
February 09, 2023 14:59 - 23 minutes - 32 MBThe U.S. Food and Drug Administration (FDA) recently issued a final guidance document clarifying how the agency intends to regulate clinical decision support software (CDS). How has this document caused confusion for industry? How can companies respond? On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA's latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply, with that guidance. Visit o...
The PACE Program: What Changes May Be Coming Soon?
February 02, 2023 15:07 - 32 minutes - 44.8 MBChanges are on the horizon for provisions of the Program of All-Inclusive Care for the Elderly (PACE) that haven't been updated in over a decade. What exactly is PACE and how will new proposed rule modifications affect PACE plans moving forward? On this episode, special guest Wendy Edwards, Director of Internal Operations at BluePeak Advisors, and Epstein Becker Green attorneys Lynn Shapiro Snyder, Kevin Malone, and Helaine Fingold explore the ins and outs of PACE, the changes in recent yea...
Post-Dobbs: Considerations for Clinical Trials and Research
January 26, 2023 14:53 - 24 minutes - 34.3 MBThe Dobbs v. Jackson Women's Health Organization decision, which effectively removed the federal constitutional protections for abortion, triggered a series of changes for health care providers and patients alike across the nation with respect to abortion services. What additional implications are there for certain aspects of clinical trials and research? On this episode, Epstein Becker Green attorneys Kate Heffernan, Marylana Helou, and Megan Robertson discuss how the changing state laws a...
2023 Health Policy Outlook
January 12, 2023 16:09 - 36 minutes - 49.9 MBWith the recent midterm elections changing the composition of Congress, and the Biden administration's first opportunities to advance its policy priorities from the very beginning of the rulemaking process, what are the key health care developments to watch out for in 2023? On this episode, Epstein Becker Green attorneys Ted Kennedy, Jr., Alexis Boaz, and Philo Hall discuss the current landscape of health care policy from both the legislative and regulatory perspectives and analyze which key...
Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
December 01, 2022 15:02 - 22 minutes - 30.4 MBIn the aftermath of the Dobbs v. Jackson Women's Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been used to induce abortions. How can health care providers and pharmacies navigate these new restrictions? On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharm...
Owner's Outlook: National Trends in Construction Claims
November 17, 2022 16:00 - 29 minutes - 40.4 MBThe past three years have been tumultuous in the health care construction economy, and the patterns in recent construction claims might surprise some. Which types of claims are popping up, in what regions are they appearing, and what types of facilities are involved? On this episode of our Owner's Outlook series, special guest Brett Lamb, co-founder and CEO of Construction Discovery Experts, and construction attorney Chris Dunn analyze recent national trends in construction claims and discus...
Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape
November 03, 2022 15:25 - 38 minutes - 52.8 MBFollowing the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, some states have banned abortion in all or most circumstances and many more have enacted new restrictions or enforced old ones. What must providers and health care leaders understand about this patchwork of laws, the ongoing enforcement activity, and protecting their organization's interests? On this episode, Epstein Becker Green attorneys Jenny Nelson Carney, Stuart Gerson, Erin Sutton, and Dan Fahey dis...
Health Care's Past, Present, and Future
October 27, 2022 14:35 - 46 minutes - 65.3 MBIn celebration of the 50th episode of our Diagnosing Health Care podcast, we're looking at how the past 50 years of health law will impact health care in the next 50 years. On this episode, Epstein Becker Green attorneys Mark Lutes; Lynn Shapiro Snyder; Ted Kennedy, Jr.; and Nivedita Patel talk about the past, present, and future solutions to a fundamental question: How can the United States manage health care spending while continuing to provide access to high-quality health care products a...
Hot Areas in COVID-19 Enforcement, Testing, and Funding
September 22, 2022 12:57 - 27 minutes - 37.9 MBWhile the COVID-19 pandemic seems to be moving into our rearview mirror, government investigations and enforcement actions targeting COVID-19-related fraud are just starting to heat up. What can businesses do to prevent or mitigate potential civil and criminal charges in this area? On this episode, Epstein Becker Green attorneys Melissa Jampol, Erica Sibley Bahnsen, and Rachel Weisblatt discuss COVID-19 relief funding programs that are now subject to enforcement actions, the type of governme...
Owner's Outlook: HCA's Clint Russell on Health Care Construction Pricing and Innovation
September 15, 2022 12:49 - 45 minutes - 63.1 MBSince the beginning of 2022, prices for construction services and materials have seen significant increases. How have these increases impacted the advancement of both new and ongoing health care construction projects? On this episode of our Owner's Outlook series, Clint Russell, Vice President at HCA Healthcare, and construction attorney Chris Dunn talk about where costs are increasing, what might lie ahead, and how owners and providers can navigate a way forward for projects in the health c...
Owner’s Outlook: Maximize and Safeguard Reimbursement Through Design
September 01, 2022 15:03 - 33 minutes - 46 MBThe COVID-19 pandemic kicked off a pivot in health care construction and design, and acute care facilities have been rapidly renovating to adapt their spaces to evolving public health care needs. On this episode of our Owner's Outlook series, attorneys Chris Dunn and David Johnston discuss how owners could see unintended consequences from designing projects without the input of skilled regulatory compliance professionals or sound construction lawyers. Visit our site for more information an...
Interoperability: Information Blocking Claims and Enforcement
August 25, 2022 14:15 - 36 minutes - 51.1 MBHow have complaints of information blocking been submitted to the Office of the National Coordinator (ONC), and by whom? What does government enforcement action really look like? In this episode of our special series on interoperability, hear from ONC attorneys Cassie Weaver and Rachel Nelson. Cassie, Rachel, and Epstein Becker Green attorneys Allen Killworth and Nivedita Patel discuss how to better understand the formal information blocking complaint process, trends ONC has observed, and ...
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
August 11, 2022 16:31 - 32 minutes - 44.6 MBFor years, pharmacy advocates have urged policymakers to make changes to state scope of practice laws that would permit pharmacists to prescribe and administer certain tests and vaccines at the pharmacy. How has COVID-19 impacted these efforts? In this episode, special guest Will Chang, Chief Legal Officer of UpStream, and attorneys Richard Hughes and Kala Shankle discuss the history of pharmacists' scope of practice before the pandemic, how the response to COVID-19 shifted pharmacists’ role...
Owner’s Outlook: Renovating and Expanding Critical Access Hospitals in a Volatile Market
August 04, 2022 14:45 - 29 minutes - 40.6 MBOver the last 12–24 months, Critical Access Hospitals have seen steep cost escalation in their expansion and renovation plans, with expense increases exceeding 10 percent. On this episode of our Owner's Outlook series, special guest Eric Shell, Chairman of Stroudwater Associates, and construction attorney Chris Dunn discuss how these hospitals can grow amid an array of challenges and what they should consider before their next expansion or development project. Visit our site for more infor...
Interoperability: Health Care's Next Disruptor Is openEHR
July 28, 2022 13:33 - 26 minutes - 37.3 MBHow is openEHR transforming the way health data is managed and stored across Europe? Will it soon disrupt the U.S. marketplace? In this episode of our special series on interoperability, hear from Alastair Allen, CTO of Better. Alastair and Epstein Becker Green attorneys Karen Mandelbaum and Nivedita Patel discuss how openEHR is already being applied in such places as London and France and how examples like these could quickly become more common in the United States. Visit our site for m...
Interoperability: A New Vision Through openEHR
July 14, 2022 14:25 - 22 minutes - 31 MBIn the past decade, certified electronic health records (EHRs) have been instrumental in transforming medical records from paper to digital formats. What obstacles are currently preventing providers from sharing patient data with each other or patients from sharing health information from their personal devices with their providers? In this episode of our special series on interoperability, hear from Tomaž Gornik, founder and CEO of Better. Tomaž and Epstein Becker Green attorneys Karen Ma...
Owner's Outlook: Health Care Construction in a Period of Labor Shortages / Cost Inflation
June 28, 2022 14:03 - 24 minutes - 34.3 MBStaffing challenges and cost inflation are seriously impacting health care construction as well as other sectors of the U.S. construction economy. In this episode of our Owner's Outlook series, hear from special guest Mike Noli, founder of the NoliWhite Group. Mike and Epstein Becker Green construction attorney Chris Dunn break down which projects are at greatest risk and how to successfully manage these projects amid the current market pressures. Visit our site for more information and re...
OSHA's Permanent COVID-19 Standard and Enforcement Blitz
May 24, 2022 14:59 - 28 minutes - 40 MBWhat challenges are providers likely to face as the Occupational Safety and Health Administration (OSHA) prepares its permanent COVID-19 standard for health care workers? Attorneys Denise Dadika, Bob O'Hara, and Tim Murphy review the provisions of OSHA’s temporary COVID-19 standard for health care workers, what's expected to change under the permanent rules, and the impact of the agency's current enforcement push. Visit our site for related resources and email contact information: https://...
Entrepreneurship in Biotech: Growing Your Business
April 14, 2022 14:14 - 30 minutes - 27.7 MBWhat has contributed to the biotechnology industry’s explosive growth over the last several years? In this episode, special guests Don and Lisa Drakeman, two former CEOs of biotech companies, reflect on what it takes to succeed, the regulatory challenges they have faced, and how current events are shaping the future of the industry. Joining our special guests are Epstein Becker Green attorneys Robert Wanerman and Rachel Weisblatt, who address how biotech leaders, entrepreneurs, and investors...
DOJ Goes After Civil Cyber-Fraud
March 31, 2022 13:45 - 35 minutes - 33.2 MBHow does the U.S. Department of Justice (DOJ) intend to leverage its enforcement authority under the False Claims Act to advance DOJ’s recently announced Civil Cyber-Fraud Initiative? Attorneys Stuart Gerson, Alaap Shah, and Bonnie Odom discuss what this initiative means for potential defendants and what companies can do to mitigate risk. The attorneys also consider whether the initiative makes practical sense and explore some potential unintended consequences. Visit our site for related r...
Interoperability: The Role of Health Information Exchanges
March 17, 2022 14:30 - 31 minutes - 29.4 MBThe interoperability and information-blocking rules have imposed new regulations and requirements on health information exchanges (HIEs). How are HIEs responding to these new regulations in a space they have been in for decades? In this episode of our special series on interoperability, hear from Dan Paoletti, CEO of the Ohio Health Information Partnership. Dan and Epstein Becker Green attorneys Allen Killworth and Nivedita Patel discuss the role of HIEs in the interoperability landscape a...
Interoperability: The Provider Perspective
February 24, 2022 16:32 - 30 minutes - 28.1 MBOne of the long-term goals of the interoperability and information-blocking rules is to give health care providers a much more comprehensive view of a patient's entire continuum of care. In this episode, Andrea Darby, the Vice President of IT Integration – Applications for OhioHealth, offers a provider's perspective on their role in a health care ecosystem that is striving to achieve much-needed interoperability. Epstein Becker Green attorneys Jenny Nelson Carney and Nivedita Patel also ...
Owner’s Outlook: Vaccine Mandate for Construction Workers at Health Care Facilities
February 17, 2022 15:29 - 37 minutes - 34.1 MBThe Supreme Court recently upheld the Centers for Medicare and Medicaid Services (CMS) vaccine mandate, which requires recipients of federal Medicare and Medicaid funding to ensure that employees, including third-party contractors, are vaccinated against COVID-19. In the first episode of “Owner's Outlook,” a special series at the intersection of health care and construction, attorneys Chris Dunn and Frank Morris discuss the scenarios in which the CMS vaccine mandate could extend to constructi...
Chevron Deference: Is It Time for Change?
February 15, 2022 12:43 - 33 minutes - 30.9 MBThis term, the Supreme Court of the United States is set to rule in a Medicare reimbursement case that has sparked a fresh look at the historical deference often granted to agencies and whether it should remain, be modified, or even be overruled. Attorneys Stuart Gerson, Robert Wanerman, and Megan Robertson discuss why Chevron deference matters to health care industry stakeholders and what aspects of deference arguments should be in focus as these cases progress. Visit our site for more info...
Interoperability: How Far We’ve Come and Where We’re Going
February 03, 2022 13:30 - 35 minutes - 32.3 MBThe 21st Century Cures Act kicked off a major paradigm shift in the approach to accessing and sharing patient data. How will the health care industry adapt to this new way of thinking? In the first episode of our special series on interoperability, Steve Yaskin, the CEO and Co-Founder of Health Gorilla, and Epstein Becker Green’s Nivedita Patel discuss why interoperability is so important for patients and all stakeholders within the health care ecosystem. You’ll also hear about how various r...
No Surprises Act: New Rules and Guidance for Stakeholders (Part 2)
January 13, 2022 15:39 - 33 minutes - 30.5 MBThe Biden administration has released a series of rules and guidance to implement the No Surprises Act, which went into effect on January 1. All providers and facilities must now provide a good faith estimate to uninsured and self-pay patients scheduling appointments for services or upon request. Attorneys Helaine Fingold, Robert Hearn, and Alexis Boaz discuss the good faith estimate, what it entails, who needs to provide it, and updates regarding enforcement. Additionally, you’ll hear abo...
No Surprises Act: New Rules and Guidance for Stakeholders (Part 1)
December 09, 2021 15:21 - 37 minutes - 34.5 MBThe No Surprises Act (NSA) will go into effect on January 1, 2022. Since our last episode on the topic, the federal government has issued additional interim final rules and guidance to implement the NSA, including the second interim final rule. In addition to describing how the NSA interacts with the plan external review procedures, the second interim final rule describes the independent dispute resolution (IDR) process and how the IDR's determination is made. Hear from attorneys Helaine F...
How Will Biden’s Executive Order Impact Future Hospital Mergers?
November 22, 2021 14:32 - 39 minutes - 36.7 MBWe’re beginning to see how mergers and acquisitions in the hospital industry are being impacted by President Biden’s executive order promoting competition in the American economy. The Federal Trade Commission recently announced policy changes, and the Department of Justice has been asked to consider policy changes, that boards of directors and C-suite officers must take into account when weighing transactions. On this episode of Diagnosing Health Care, special guest Dr. Subramaniam (Subbu)...
What Is the Future of the Acute Care Hospital Industry?
November 11, 2021 14:28 - 37 minutes - 35 MBAs 2021 nears a close, acute care hospitals and health systems are facing a host of financial, regulatory, and legislative challenges. Hear Rick Pollack, President and CEO of the American Hospital Association, and Epstein Becker Green’s Ted Kennedy, Jr., discuss the ways in which the industry is working with the Biden administration and Congress to shape policy around critical issues, such as surprise billing, coverage expansion, value-based care, and telehealth. Rick and Ted look at how t...
Is the Dietary Supplement Regulatory Framework Working?
October 21, 2021 13:42 - 32 minutes - 30.2 MBThe COVID-19 pandemic spurred record growth in the dietary supplement industry in 2020. With this heightened consumer interest and many new entrants to the market, important questions have emerged about the adequacy of the current regulatory framework for dietary supplements. Are current controls adequately protecting consumers from supplement products that are unsafe? What is the right level of regulation and enforcement for these products? In this episode of Diagnosing Health Care, Epste...
No Surprises Act: Considerations for Plans and Providers
September 30, 2021 15:39 - 41 minutes - 38.1 MBOn December 27, 2020, President Trump signed into law the No Surprises Act as part of the $2.3 billion Consolidated Appropriations Act. Recently, the Biden administration issued its first interim final rule in order to implement this act, which will go into effect on January 1, 2022. While the goal is to protect patients from surprise billing, the law will also impose significant compliance burdens on plans, providers, and facilities. Epstein Becker Green attorneys Helaine Fingold, Bob Hea...
How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
August 05, 2021 15:44 - 29 minutes - 26.8 MBAlthough the COVID-19 pandemic exposed cybersecurity vulnerabilities across sectors, it has particularly challenged the resilience of information systems for health care and life sciences companies. Because ransomware attacks have the potential to cripple access to important data, expose patient health records, and shut down machinery and life-saving equipment, it's no surprise that health care executives continue to lose sleep thinking about potential ransomware or other similar malicious a...